Cara Therapeutics, Inc. (CARA) Financials

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

CARA Income statement / Annual

Last year (2025), 's total revenue was $0.00, a decrease of 100.00% from the previous year. In 2025, 's net income was -$18.21 M. See ,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2025 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $0.00 $7.14 M $20.97 M $41.87 M $23.03 M $135.08 M $19.89 M $13.47 M $911.00 K $86.00 K
Cost of Revenue $0.00 $620.00 K $6.17 M $7.27 M $1.55 M $107.07 M $113.16 M $75.53 M $48.52 M $49.25 M
Gross Profit $0.00 $6.52 M $14.54 M $34.60 M $21.47 M $28.01 M -$93.28 M -$62.06 M -$47.61 M -$49.17 M
Gross Profit Ratio 0 0.91 0.69 0.83 0.93 0.21 -4.69 -4.61 -52.26 -571.71
Research and Development Expenses $18.01 M $32.81 M $108.51 M $91.88 M $82.70 M $107.85 M $113.82 M $75.53 M $48.52 M $49.25 M
General & Administrative Expenses $8.74 M $26.39 M $27.65 M $30.26 M $29.41 M $21.75 M $17.75 M $15.32 M $11.87 M $9.23 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $8.74 M $26.39 M $27.65 M $30.26 M $29.41 M $21.75 M $17.75 M $15.32 M $11.87 M $9.23 M
Other Expenses $0.00 $5.71 M $0.00 $0.00 $642.00 K $97.00 K $4.49 M $2.98 M $1.16 M $652.00 K
Operating Expenses $26.75 M $64.90 M $136.29 M $122.14 M $112.11 M $129.70 M $131.57 M $90.85 M $60.40 M $58.49 M
Cost And Expenses $0.00 $65.52 M $142.46 M $129.40 M $112.11 M $129.70 M $131.57 M $90.85 M $60.40 M $58.49 M
Interest Income $1.38 M $0.00 $0.00 $2.06 M $603.00 K $2.06 M $4.49 M $0.00 $0.00 $0.00
Interest Expense $0.00 $8.47 M $604.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $0.00 $192.00 K $259.00 K $1.67 M $1.55 M $1.02 M $799.00 K $370.00 K $495.00 K $1.47 M
EBITDA -$26.75 M -$62.60 M -$117.65 M -$83.80 M -$88.19 M $5.59 M -$111.48 M -$77.01 M -$58.99 M -$56.94 M
EBITDA Ratio 0 -8.77 -5.61 -2 -3.83 0.04 -5.61 -5.72 -64.75 -662.03
Operating Income Ratio 0 -8.18 -5.79 -2.09 -3.87 0.04 -5.62 -5.75 -65.3 -679.07
Total Other Income/Expenses Net $8.53 M -$12.88 M $2.98 M $2.06 M $642.00 K $2.33 M $4.49 M $2.98 M $1.16 M $652.00 K
Income Before Tax -$18.21 M -$71.27 M -$118.51 M -$85.47 M -$88.44 M $7.72 M -$107.19 M -$74.40 M -$58.33 M -$57.75 M
Income Before Tax Ratio 0 -9.99 -5.65 -2.04 -3.84 0.06 -5.39 -5.52 -64.03 -671.49
Income Tax Expense $0.00 -$398.00 K $0.00 $0.00 $0.00 -$691.00 K -$816.00 K -$389.00 K -$204.00 K -$468.00 K
Net Income -$18.21 M -$70.87 M -$118.51 M -$83.41 M -$88.19 M $8.41 M -$106.37 M -$74.01 M -$58.13 M -$57.28 M
Net Income Ratio 0 -9.93 -5.65 -1.99 -3.83 0.06 -5.35 -5.5 -63.8 -666.05
EPS -2.46 -1.55 -2.19 -1.55 -1.74 0.18 -2.49 -2.06 -1.86 -2.1
EPS Diluted -3.26 -1.55 -2.19 -1.55 -1.74 0.18 -2.49 -2.06 -1.86 -2.1
Weighted Average Shares Out $7.42 B $45.63 M $54.12 M $53.65 M $50.72 M $47.41 M $42.67 M $35.89 M $31.20 M $27.28 M
Weighted Average Shares Out Diluted $7.78 B $45.63 M $54.15 M $53.65 M $50.72 M $47.92 M $42.67 M $35.89 M $31.20 M $27.28 M
Link